| James Bylund |
RGEN |
Common Stock |
Tax liability |
-0.35% |
|
|
-62 |
17,672 |
04 Mar 2026 |
Direct |
| James Bylund |
RGEN |
Common Stock |
Award |
0.71% |
|
|
125 |
17,734 |
04 Mar 2026 |
Direct |
| RALF KURIYEL |
RGEN |
Common Stock |
Tax liability |
-0.28% |
|
|
-42 |
14,778 |
04 Mar 2026 |
Direct |
| RALF KURIYEL |
RGEN |
Common Stock |
Award |
0.85% |
|
|
125 |
14,820 |
04 Mar 2026 |
Direct |
| James Bylund |
RGEN |
Common Stock |
Tax liability |
-12.1% |
|
|
-2,433 |
17,609 |
02 Mar 2026 |
Direct |
| Olivier Loeillot |
RGEN |
Common Stock |
Tax liability |
-4.53% |
|
|
-1,610 |
33,944 |
02 Mar 2026 |
Direct |
| Anthony Hunt |
RGEN |
Common Stock |
Tax liability |
-10% |
|
|
-9,897 |
89,062 |
02 Mar 2026 |
Direct |
| Jason K. Garland |
RGEN |
Common Stock |
Tax liability |
-5.48% |
|
|
-715 |
12,341 |
02 Mar 2026 |
Direct |
| RALF KURIYEL |
RGEN |
Common Stock |
Tax liability |
-5.91% |
|
|
-923 |
14,695 |
02 Mar 2026 |
Direct |
| Brian Robb Douglass |
RGEN |
Common Stock |
Tax liability |
-2.59% |
|
|
-221 |
8,319 |
02 Mar 2026 |
Direct |
| James Bylund |
RGEN |
Common Stock |
Tax liability |
-6.87% |
|
|
-1,478 |
20,042 |
27 Feb 2026 |
Direct |
| Olivier Loeillot |
RGEN |
Common Stock |
Tax liability |
-0.96% |
|
|
-344 |
35,554 |
27 Feb 2026 |
Direct |
| Jason K. Garland |
RGEN |
Common Stock |
Tax liability |
-2.44% |
|
|
-327 |
13,056 |
27 Feb 2026 |
Direct |
| RALF KURIYEL |
RGEN |
Common Stock |
Tax liability |
-2.76% |
|
|
-444 |
15,618 |
27 Feb 2026 |
Direct |
| Brian Robb Douglass |
RGEN |
Common Stock |
Award |
36.6% |
|
|
2,288 |
8,540 |
31 Dec 2025 |
Direct |
| Brian Robb Douglass |
RGEN |
Stock Option (Right to Buy) |
Award |
|
|
|
2,143 |
2,143 |
31 Dec 2025 |
Direct |
| KAREN A. DAWES |
RGEN |
Common Stock |
Sale |
-0.3% |
$44,275 |
$161.00 |
-275 |
91,821 |
17 Dec 2025 |
Direct |
| GLENN P. MUIR |
RGEN |
Common Stock |
Options Exercise |
10.1% |
|
|
3,366 |
36,622 |
16 Dec 2025 |
Direct |
| GLENN P. MUIR |
RGEN |
Stock Option (Right to Buy) |
Options Exercise |
|
|
|
3,366 |
3,366 |
16 Dec 2025 |
Direct |
| Anthony Hunt |
RGEN |
Common Stock |
Other |
-1.98% |
|
|
-2,000 |
98,959 |
04 Dec 2025 |
Direct |
| Olivier Loeillot |
RGEN |
Common Stock |
Sale |
-16.4% |
$1,196,970 |
$170.00 |
-7,041 |
35,898 |
25 Nov 2025 |
Direct |
| James Bylund |
RGEN |
Common Stock |
Sale |
-9.24% |
$331,301 |
$151.21 |
-2,191 |
21,520 |
18 Nov 2025 |
Direct |
| Anthony Hunt |
RGEN |
Common Stock |
Options Exercise |
3.66% |
|
|
2,952 |
83,695 |
13 Nov 2025 |
Direct |
| Anthony Hunt |
RGEN |
Common Stock |
Sale |
-19.8% |
$3,092,278 |
$154.61 |
-20,000 |
80,743 |
13 Nov 2025 |
Direct |
| Anthony Hunt |
RGEN |
Stock Option (Right to Buy) |
Options Exercise |
25% |
|
|
2,952 |
14,760 |
13 Nov 2025 |
Direct |
| Anthony Hunt |
RGEN |
Common Stock |
Sale |
-19.9% |
$3,921,940 |
$156.88 |
-25,000 |
100,743 |
12 Nov 2025 |
Direct |
| Anthony Hunt |
RGEN |
Common Stock |
Options Exercise |
24.8% |
|
|
25,000 |
125,743 |
12 Nov 2025 |
Direct |
| Anthony Hunt |
RGEN |
Stock Option (Right to Buy) |
Options Exercise |
-13.7% |
|
|
-25,000 |
157,344 |
12 Nov 2025 |
Direct |
| Olivier Loeillot |
RGEN |
Common Stock |
Tax liability |
-2.82% |
|
|
-1,248 |
42,939 |
02 Oct 2025 |
Direct |
| Jason K. Garland |
RGEN |
Common Stock |
Tax liability |
-2.99% |
|
|
-412 |
13,383 |
25 Sep 2025 |
Direct |
| Anthony Hunt |
RGEN |
Common Stock |
Sale |
-22.4% |
$3,508,389 |
$120.52 |
-29,111 |
100,743 |
10 Sep 2025 |
Direct |
| Anthony Hunt |
RGEN |
Common Stock |
Options Exercise |
18.2% |
|
|
20,000 |
129,854 |
10 Sep 2025 |
Direct |
| Anthony Hunt |
RGEN |
Stock Option (Right to Buy) |
Options Exercise |
-9.88% |
|
|
-20,000 |
182,344 |
10 Sep 2025 |
Direct |
| Olivier Loeillot |
RGEN |
Common Stock |
Tax liability |
-5.37% |
|
|
-2,506 |
44,187 |
03 Sep 2025 |
Direct |
| Violetta Hughes |
RGEN |
Common Stock |
Award |
|
|
|
4,142 |
4,142 |
02 Sep 2025 |
Direct |
| Violetta Hughes |
RGEN |
Stock Option (Right to Buy) |
Award |
|
|
|
3,914 |
3,914 |
02 Sep 2025 |
Direct |
| Martin D. Madaus |
RGEN |
Common Stock |
Purchase |
|
$201,830 |
$112.13 |
1,800 |
1,800 |
08 Aug 2025 |
By Martin D. Madaus 2011 Revocable Trust |
| NICOLAS BARTHELEMY |
RGEN |
Common Stock |
Award |
28.1% |
|
|
973 |
4,441 |
15 May 2025 |
Direct |
| NICOLAS BARTHELEMY |
RGEN |
Stock Option (Right to Buy) |
Award |
|
|
|
1,800 |
1,800 |
15 May 2025 |
Direct |
| Konstantin Konstantinov |
RGEN |
Common Stock |
Award |
50.6% |
|
|
973 |
2,894 |
15 May 2025 |
Direct |
| Konstantin Konstantinov |
RGEN |
Stock Option (Right to Buy) |
Award |
|
|
|
1,800 |
1,800 |
15 May 2025 |
Direct |
| GLENN P. MUIR |
RGEN |
Common Stock |
Award |
3.01% |
|
|
973 |
33,256 |
15 May 2025 |
Direct |
| GLENN P. MUIR |
RGEN |
Stock Option (Right to Buy) |
Award |
|
|
|
1,800 |
1,800 |
15 May 2025 |
Direct |
| MANNER CARRIE EGLINTON |
RGEN |
Common Stock |
Award |
27.9% |
|
|
973 |
4,466 |
15 May 2025 |
Direct |
| MANNER CARRIE EGLINTON |
RGEN |
Stock Option (Right to Buy) |
Award |
|
|
|
1,800 |
1,800 |
15 May 2025 |
Direct |
| KAREN A. DAWES |
RGEN |
Common Stock |
Award |
1.07% |
|
|
973 |
92,096 |
15 May 2025 |
Direct |
| KAREN A. DAWES |
RGEN |
Stock Option (Right to Buy) |
Award |
|
|
|
1,800 |
1,800 |
15 May 2025 |
Direct |
| Martin D. Madaus |
RGEN |
Common Stock |
Award |
21.1% |
|
|
973 |
5,586 |
15 May 2025 |
Direct |
| Martin D. Madaus |
RGEN |
Stock Option (Right to Buy) |
Award |
|
|
|
1,800 |
1,800 |
15 May 2025 |
Direct |
| Margaret Pax |
RGEN |
Common Stock |
Award |
93.3% |
|
|
973 |
2,016 |
15 May 2025 |
Direct |